Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Drug Targeting|September 17, 2015
Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancerTara Pritchard, Rhonda J Rosengren, Khaled Greish, et al.Health Information Management : Journal of the Health Information Management Association of Australia|July 10, 2020
A qualitative investigation into clinical documentation: why do clinicians document the way they do?Stella Rowlands, Amina Tariq, Steven Coverdale, et al.Journal of Drug Targeting|January 8, 2019
Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptorKhaled Greish, Hayley Nehoff, Fatemah Bahman, et al.International Journal of Nanomedicine|January 27, 2016
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancerMonica Archibald, Tara Pritchard, Hayley Nehoff, et al.Clinical & Translational Immunology|July 7, 2022
Glycolipid-peptide conjugate vaccines elicit CD8<sup>+</sup> T-cell responses and prevent breast cancer metastasisOlivia K Burn, Kathryn Farrand, Tara Pritchard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, JianXin Duan, Tara Pritchard, et al.Leukemia|December 19, 2019
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemiaKlaartje Somers, Kathryn Evans, Leanna Cheung, et al.Cancer Cell|December 11, 2019
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged LeukemiaAndrei V Krivtsov, Kathryn Evans, Jayant Y Gadrey, et al.Pageof 1